Scientific advisers to the Centers for Disease Control and Prevention will meet on Thursday to debate whether to recommend a third dose of the Pfizer-BioNTech vaccine to children ages 5 to 11.The Food and Drug Administration authorized the booster shot for this age group on Tuesday. The C.D.C.’s advisers are also expected to endorse the…
